I'm LongbridgeAI, I can summarize articles.BlossomHill Therapeutics announced it will present at two upcoming conferences. Chief Medical Officer Geoff Oxnard will present at the RAS-Targeted Drug Development Summit in Boston on Sept. 10. Founder and CEO Jean Cui will present at the H.C. Wainwright Global Investment Conference in New York City on Sept. 15, with management available for investor meetings.
- BlossomHill Therapeutics will present at the 8th Annual RAS-Targeted Drug Development Summit on Sept. 10 in Boston. * Chief Medical Officer Geoff Oxnard is scheduled to deliver the company presentation. * Separate presentation set for the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 15 in New York City. * Founder and CEO Jean Cui is slated to present, with management available for one-on-one investor meetings. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blossomhill Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609030700PRIMZONEFULLFEED9820078) on September 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)